Company: XAIR
Filing Date: 2025-08-12
Form Type: 10-Q
Source: 0001641172-25-023243
Chunk: 32

Company: Beyond Air, Inc.
Filing Date: 2025-08-12
Form: 10-Q
Item: Part I, Item 1
Chunk 32
---
    $0.14  
     9.0  
    $3,501 
  
    Granted 
     156,000  
     3.00  
     -  
     - 
  
    Exercised 
     -  
     -  
     -  
     - 
  
    Forfeited 
     (1,435) 
     0.14  
     -  
     - 
  
    Outstanding as of June 30, 2025 
     1,378,704  
    $0.46  
     8.5  
    $3,497 
  
    Exercisable as of June 30, 2025 
     306,035  
    $0.14  
     8.8  
    $875 

As
of June 30, 2025, the Company had unrecognized stock-based compensation expense for the stock options in the 2023 NNOS Plan of approximately
$0.4 million, which is expected to be expensed over the weighted average remaining service period of 1.8 years.

For
the three months June 30, 2025, the weighted average fair value of options granted was $2.38 per share.

    17

BEYOND
AIR, INC. AND SUBSIDIARIES

NOTES
TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED)

NOTE
4 STOCKHOLDERS’ EQUITY (continued)

The
following was utilized to calculate the fair value of options on the date of grant:

SCHEDULE OF FAIR VALUE OF OPTION  

    June 30, 2025  
    June 30, 2024 
  
    Risk-free interest rate 
     4.0 – 4.2% 
     4.3 – 4.5%
  
    Expected volatility (Beyond Air) 
     91.6 – 95.7% 
     83.5 – 83.8%
  
    Expected volatility (Beyond Cancer) 
     -% 
     -%
  
    Expected volatility (NeuroNos) 
     95.0% 
     -%
  
    Dividend yield 
     0% 
     0%
  
    Expected terms (in years) 
     6.25  
     6.25